| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00432-003-0511-1 |
| P698 | PubMed publication ID | 14685850 |
| P2093 | author name string | Lu Wang | |
| Yan Li | |||
| Jian Zhou | |||
| Jia Fan | |||
| Shuang-Jian Qiu | |||
| Zhao-You Tang | |||
| Zhi-Quan Wu | |||
| Sheng-Long Ye | |||
| Hu Liu | |||
| Lun-Xiu Qin | |||
| Hui-Chuan Sun | |||
| Yin-Kun Liu | |||
| Kang-Da Liu | |||
| Qin-Hai Ye | |||
| Xin-Da Zhou | |||
| Zeng-Chen Ma | |||
| Zhi-Ying Lin | |||
| Xue-Ning Ji | |||
| Jing-Ling Xia | |||
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver | Q24555051 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Genomic analysis of metastasis reveals an essential role for RhoC | Q28144278 | ||
| Cancer statistics, 2002 | Q28216788 | ||
| Hepatocellular carcinoma: from bedside to proteomics | Q30768305 | ||
| Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins | Q30874217 | ||
| The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis | Q30884796 | ||
| Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials | Q30978623 | ||
| Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization | Q33336700 | ||
| Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial | Q33871980 | ||
| Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial | Q33920539 | ||
| Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. | Q34445340 | ||
| Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials | Q34953308 | ||
| Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials | Q35101345 | ||
| Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma | Q73969919 | ||
| Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma | Q74303893 | ||
| [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma] | Q74386721 | ||
| Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients | Q74404919 | ||
| Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma | Q74453200 | ||
| Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 | Q74484550 | ||
| The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma | Q74551465 | ||
| Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma | Q74595261 | ||
| Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients | Q74787904 | ||
| Prognostic value of serum biological markers in patients with hepatocellular carcinoma | Q77161685 | ||
| Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma | Q77215000 | ||
| [The role of MMP-2 in the invasion and metastasis of hepatocellular carcinoma (HCC)] | Q77411399 | ||
| [Changes of PAI-1 and biological behaviour of human hepatocellular carcinoma in metastatic model of nude mice] | Q77589503 | ||
| Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma | Q77666715 | ||
| KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases | Q77813158 | ||
| The abundance of NM23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepato-cellular carcinoma | Q77813176 | ||
| Microvessel density of hepatocellular carcinoma: its relationship with prognosis | Q77965086 | ||
| Alterations of CDKN2(p16/MTS1) exon 2 in human hepatocellular carcinoma | Q84144955 | ||
| P53 mutations may be related to tumor invasiveness of human hepatocellular-carcinoma in china | Q84152637 | ||
| The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. | Q36209697 | ||
| P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection | Q36308536 | ||
| Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. | Q36415612 | ||
| Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. | Q36492038 | ||
| Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. | Q36618179 | ||
| Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells | Q37352612 | ||
| New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis | Q38273658 | ||
| The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma | Q38336028 | ||
| The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential | Q38483960 | ||
| Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice | Q39592414 | ||
| alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study | Q40650650 | ||
| A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. | Q40774045 | ||
| Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared | Q40786571 | ||
| Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. | Q41005703 | ||
| Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization | Q43569197 | ||
| Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials | Q43645553 | ||
| Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours | Q44198326 | ||
| Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning | Q45728735 | ||
| Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer | Q45741344 | ||
| Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. | Q47262968 | ||
| Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. | Q47595760 | ||
| Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma | Q47866457 | ||
| Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
| Angiogenesis inhibitors: motivators of metastasis? | Q51665369 | ||
| Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. | Q53318354 | ||
| Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. | Q53833521 | ||
| Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma. | Q54217111 | ||
| Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. | Q54766147 | ||
| Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues | Q71007109 | ||
| Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group | Q71073938 | ||
| Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype | Q71858038 | ||
| Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray | Q73083120 | ||
| Inhibitory effects of synthetic beta peptide on invasion and metastasis of liver cancer | Q73106338 | ||
| Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor | Q73193733 | ||
| Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes | Q73215323 | ||
| The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma | Q73229768 | ||
| N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice | Q73292148 | ||
| Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | Q73370593 | ||
| Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | Q73435945 | ||
| From the molecule to the clinic--inhibiting HER2 to treat breast cancer | Q73614009 | ||
| Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma | Q73623064 | ||
| Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma | Q73686811 | ||
| Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20 | Q73736400 | ||
| High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential | Q73929826 | ||
| Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy | Q73934500 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 187-196 | |
| P577 | publication date | 2003-12-18 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | A decade's studies on metastasis of hepatocellular carcinoma | |
| P478 | volume | 130 |
| Q39027664 | A Huaier polysaccharide reduced metastasis of human hepatocellular carcinoma SMMC-7721 cells via modulating AUF-1 signaling pathway |
| Q54363774 | A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery. |
| Q36934253 | A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma |
| Q36089938 | A morpho-molecular prognostic model for hepatocellular carcinoma |
| Q33576268 | A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. |
| Q36962630 | A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells |
| Q51080130 | A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. |
| Q39622601 | A three-dimensional cell biology model of human hepatocellular carcinoma in vitro |
| Q47184580 | A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up. |
| Q38816095 | ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell. |
| Q38899847 | Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells. |
| Q36562108 | Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma |
| Q37662243 | Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression |
| Q39310796 | Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion |
| Q41271096 | Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors |
| Q37681702 | Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study |
| Q34130424 | Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration |
| Q38893513 | Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation |
| Q35741034 | Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma |
| Q39360242 | Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma |
| Q54964792 | Antitumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo. |
| Q36623880 | Anti‑angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential |
| Q36111028 | Application of proteomics in the study of tumor metastasis |
| Q39663444 | Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells |
| Q41759557 | Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population |
| Q44767535 | Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus-related hepatocellular carcinoma in a Chinese Han population |
| Q50883910 | Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma. |
| Q39070884 | Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells |
| Q47407747 | BCA3 contributes to the malignant progression of hepatocellular carcinoma through AKT activation and NF-κB translocation |
| Q33376050 | Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma |
| Q37377240 | CAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor Microenvironment |
| Q47123384 | CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma |
| Q57473743 | CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling |
| Q33903701 | Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma |
| Q42434764 | Chemoembolization and stenting combined with iodine-125 seed strands for the treatment of hepatocellular carcinoma with inferior vena cava obstruction |
| Q34159714 | Clinicopathological Significance of Expression of Tspan-1, Jab1 and p27 in Human Hepatocellular Carcinoma |
| Q35550129 | Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma |
| Q58321603 | Clusterin plays an important role in hepatocellular carcinoma metastasis |
| Q39388167 | Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma |
| Q50700900 | Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection. |
| Q39604837 | Comparison of alternative extraction methods for secretome profiling in human hepatocellular carcinoma cells |
| Q38765553 | Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line |
| Q34078634 | Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells |
| Q34783772 | Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy |
| Q33751830 | Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation |
| Q37212974 | Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. |
| Q34634386 | Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma |
| Q53269544 | Down-regulation of SDF1-α expression in tumor microenvironment is associated with aspirin-mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma. |
| Q24336278 | Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma |
| Q35116051 | Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma |
| Q35402681 | Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma |
| Q64980934 | EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis. |
| Q39251014 | Effect of PI3K gene silencing on growth, migration and related proteins expression of CD40 signal-mediated gastric cancer cells |
| Q36900631 | Effect of thalidomide on the proliferation of hepatoma cells assessed by osteopontin levels in nude mice. |
| Q98386375 | Enhanced therapeutic effect of transcatheter arterial chemoembolization combined with radioactive I-125 seed implantation on liver cancer |
| Q39653490 | Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma |
| Q35741127 | Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis. |
| Q36967467 | Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue |
| Q39290981 | Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma |
| Q37462365 | Experimental models of hepatocellular carcinoma: developments and evolution |
| Q33844068 | Expression and clinical significance of FXYD3 in endometrial cancer |
| Q37402206 | Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence |
| Q34795631 | FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma |
| Q57998678 | Factors Associated with Disease Survival after Surgical Resection in Chinese Patients with Hepatocellular Carcinoma |
| Q33732998 | Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma |
| Q34827266 | FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. |
| Q33692511 | Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness |
| Q38366329 | Glycosylation and liver cancer |
| Q34400426 | Goosecoid promotes the metastasis of hepatocellular carcinoma by modulating the epithelial-mesenchymal transition |
| Q49953063 | HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition |
| Q93187619 | HSF1: a mediator in metabolic alteration of hepatocellular carcinoma cells in cross-talking with tumor-associated macrophages |
| Q40356029 | HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma |
| Q38725577 | Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential |
| Q33567426 | Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway |
| Q36646019 | Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma |
| Q55211469 | Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. |
| Q38866174 | Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. |
| Q34633249 | Hepatocellular carcinoma: insight from animal models |
| Q38765991 | Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells |
| Q35877361 | Herbal Compound Songyou Yin and Moderate Swimming Suppress Growth and Metastasis of Liver Cancer by Enhancing Immune Function |
| Q39874427 | Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential |
| Q39411944 | High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma |
| Q35584172 | High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection |
| Q45924805 | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. |
| Q98289223 | High-throughput sequencing-based analysis of gene expression of hepatitis B virus infection-associated human hepatocellular carcinoma |
| Q38261073 | Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression. |
| Q92460190 | Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma |
| Q90259991 | Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis |
| Q58711396 | Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis |
| Q54217314 | IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. |
| Q38290607 | Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma |
| Q40013131 | Identification of local and circulating cancer stem cells in human liver cancer |
| Q39983663 | Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials |
| Q53218066 | Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma. |
| Q34886124 | In vitro invasive pattern of hepatocellular carcinoma cell line HCCLM9 based on three-dimensional cell culture and quantum dots molecular imaging |
| Q37225469 | In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins |
| Q51061616 | Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival. |
| Q37362866 | Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract. |
| Q42283456 | Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection |
| Q54539298 | Inhibition of HBV gene expression and replication by stably expressed interferon-alpha1 via adeno-associated viral vectors. |
| Q39206134 | Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells |
| Q33868191 | Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo |
| Q37457852 | JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling |
| Q37728188 | Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro |
| Q40128358 | Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195. |
| Q34120311 | Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging |
| Q35740127 | Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules |
| Q53274537 | Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization. |
| Q55502394 | Liver regeneration accelerates hepatitis B virus-related tumorigenesis of hepatocellular carcinoma. |
| Q34976928 | Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China |
| Q64908011 | LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma. |
| Q37684026 | Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells |
| Q36340244 | Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression |
| Q49596147 | Long-Term Outcomes of Ante-Situm Resection and Auto-Transplantation in Conventionally Unresectable Hepatocellular Carcinoma: A Single-Center Experience |
| Q39730685 | Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma |
| Q45368389 | Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis |
| Q51392646 | Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect. |
| Q91644938 | MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling |
| Q37745098 | MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| Q37359619 | Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma |
| Q40702667 | Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population |
| Q91004436 | Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells |
| Q36502706 | Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma |
| Q37685247 | MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb |
| Q92099259 | MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1 |
| Q38995250 | MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase |
| Q90290624 | MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2 |
| Q30986312 | Microarray data analysis of mouse neoplasia. |
| Q53209146 | Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system. |
| Q38768613 | Modulation of the Tumor Metastatic Microenvironment and Multiple Signal Pathways by Prunella vulgaris in Human Hepatocellular Carcinoma |
| Q26799788 | Mouse models of liver cancer: Progress and recommendations |
| Q35064045 | N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry |
| Q41611325 | NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma |
| Q37702157 | NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7. |
| Q37707067 | NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway |
| Q38441703 | Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells |
| Q39628244 | Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression |
| Q58794876 | Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway |
| Q37703338 | Osteopontin: an effector and an effect of tumor metastasis. |
| Q84405957 | Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma |
| Q39310276 | Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma |
| Q50140280 | Overexpression of RHEB is associated with metastasis and poor prognosis in hepatocellular carcinoma |
| Q34186021 | Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma |
| Q55478019 | Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis. |
| Q39614988 | Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells |
| Q37588358 | Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection |
| Q58617725 | Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation |
| Q35913323 | Oxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2. |
| Q36949589 | Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer |
| Q42469864 | Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma |
| Q36298565 | Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma |
| Q38977768 | Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells |
| Q34995167 | Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways |
| Q40240424 | Predictive value of microRNA-143 in evaluating the prognosis of patients with hepatocellular carcinoma |
| Q43285541 | Preparation, pharmacokinetics, tissue distribution and antitumor effect of sorafenib-incorporating nanoparticles in vivo |
| Q45791166 | Preserving hepatic artery flow during portal triad blood inflow occlusion reduces the outgrowth of hepatocarcinoma in mice after ischemia-reperfusion |
| Q43700479 | Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial |
| Q33980954 | Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis. |
| Q37534070 | Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis |
| Q34758849 | Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3. |
| Q35096817 | Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis |
| Q53086985 | Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. |
| Q45864858 | Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma |
| Q58597554 | Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis |
| Q37182260 | Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma |
| Q35216085 | Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma |
| Q54782190 | Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. |
| Q34045477 | Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation. |
| Q36905652 | Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma |
| Q54633140 | Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. |
| Q38128804 | Quality assessment of clinical research on liver cancer treated by intra-arterial infusion of Chinese medicine |
| Q34581453 | Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells |
| Q50453050 | Quercetin Induces Antiproliferative Activity Against Human Hepatocellular Carcinoma (HepG2) Cells by Suppressing Specificity Protein 1 (Sp1). |
| Q38601575 | RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma |
| Q58609658 | Recent progress in the emerging role of exosome in hepatocellular carcinoma |
| Q40756956 | Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population |
| Q39759248 | Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma |
| Q37301807 | Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma |
| Q41744534 | Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population |
| Q47140908 | Role of exosomes in hepatocellular carcinoma cell mobility alteration |
| Q92839066 | SATB2 induces stem-like properties and promotes epithelial-mesenchymal transition in hepatocellular carcinoma |
| Q38925751 | SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma |
| Q47123408 | Selection of internal references for qRT-PCR assays of human hepatocellular carcinoma cell lines |
| Q40264763 | Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients |
| Q42241053 | Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma |
| Q34894246 | Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis |
| Q36825998 | Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells |
| Q35405060 | Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model |
| Q35063797 | Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells |
| Q40971187 | Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells |
| Q47143181 | Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1. |
| Q47904094 | Spectroscopic investigation and in vitro cytotoxic activity toward HepG2 cells of a copper compound complexed with human serum albumin |
| Q58579029 | Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma |
| Q34544599 | Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo |
| Q39563873 | Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis |
| Q46151710 | TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis |
| Q38056849 | Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. |
| Q34669811 | Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells |
| Q37457973 | Tetraspanin-8 promotes hepatocellular carcinoma metastasis by increasing ADAM12m expression |
| Q41611100 | The DLGAP family: neuronal expression, function and role in brain disorders |
| Q88357678 | The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma |
| Q35958822 | The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers |
| Q36647336 | The hepatic transcriptome in human liver disease |
| Q55002211 | The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA. |
| Q40680671 | The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer |
| Q34483637 | The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway |
| Q38853674 | The nanomechanical signature of liver cancer tissues and its molecular origin |
| Q50581869 | The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization. |
| Q79756613 | The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma |
| Q50300788 | The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma. |
| Q89942007 | The role of hydrogen peroxide-inducible clone-5 in tumor progression |
| Q39709255 | The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas. |
| Q38598300 | The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein |
| Q34503882 | Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression |
| Q33598435 | Treatment with the herbal formula Songyou Yin inhibits epithelial-mesenchymal transition in hepatocellular carcinoma through downregulation of TGF-β1 expression and inhibition of the SMAD2/3 signaling pathway |
| Q81083940 | Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor |
| Q39664884 | Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma |
| Q36414399 | Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma |
| Q90632828 | Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression |
| Q45733656 | Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. |
| Q53566522 | ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. |
| Q38955621 | miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma |
| Q90608638 | miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop |
| Q36771909 | miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma |
| Q38804742 | miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis |
| Q59800874 | miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling |
| Q64059124 | miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway |
| Q39604806 | p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways |
Search more.